← All organizations

Alzheimer's Clinical Trial Consortium (ACTC)

Academic/Hospital

Also known as: Alzheimer's Clinical Trial Consortium (ACTC) | Alzheimer's Clinical Trials Consortium

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Aug 1, 2026

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 8 trials)

Phase 4 (1 own, 0 via acquisition)

donanemab

Phase 3 (1 own, 0 via acquisition)

LECANEMAB

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT06911944CollaboratorPhase 4Aug 1, 2026
NCT07264283CollaboratorPhase 2Dec 1, 2025
NCT07217665CollaboratorPhase 2Dec 1, 2025
NCT07173803CollaboratorPhase 2Dec 1, 2025
NCT06957418CollaboratorPhase 2Nov 1, 2025
NCT05644262CollaboratorPhase 2Jan 31, 2023
NCT05531656CollaboratorPhase 2Dec 31, 2022
NCT04468659CollaboratorPhase 3Jul 13, 2020
NCT04468659CollaboratorPhase 3Jul 13, 2020

Details

Last known activity: Aug 1, 2026